Navitechnologies

1 known investors

Navi Medical Technologies develops the Neonav, an ECG-based device for non-invasive real-time verification of central vascular access device (CVAD) positioning in newborns and children. The device addresses high misplacement and migration rates of CVADs through bedside monitoring to reduce complications and improve safety during critical care.